IATF eyes standardizing compensation for Covid-19 clinical trial participants
The Inter-Agency Task Force for the Management of Emerging Infectious Diseases has approved standardizing compensation for individuals participating in both WHO Solidarity Trial and independent clinical trials for Covid-19.
Participants will receive a small amount to cover their time, food, and transportation expenses.
Clinical trials are expected to start by the fourth quarter of 2020 with vaccines pre-qualified by the World Health Organization.
The Department of Science and Technology aims to ensure safety and ethical guidelines for these trials.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
Topics in this story
Explore more stories about these topics